OMX Copenhagen 20
2.095,60
PKT
+75,49
PKT
+3,74
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.05.19 | Novo Nordisk Reduce | HSBC | |
06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | UBS AG | |
02.05.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
23.04.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
15.04.19 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.04.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.03.19 | Novo Nordisk Reduce | HSBC | |
04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.02.19 | Novo Nordisk Reduce | HSBC | |
05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
04.02.19 | Novo Nordisk Neutral | Credit Suisse Group | |
02.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
14.12.18 | Novo Nordisk Equal-Weight | Morgan Stanley |